Wilmington Savings Fund Society’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
SB
BBA
RI
RG
CC
EC
CC
GPP
Wilmington Savings Fund Society's NGNE Position: Q1 2025 in Review
Wilmington Savings Fund Society sold out of Neurogene (NGNE) in Q1 2025, closing a stake of 132 shares — an estimated $3.02K sold.
Wilmington Savings Fund Society first reported a position in NGNE in Q4 2024 and held it in 1 quarter. The position peaked at $3.02K in Q4 2024. 85 funds tracked by Wall St. Rank hold NGNE as of Q1 2025.
- Wilmington Savings Fund Society reported no remaining Neurogene position as of Q1 2025 after selling out during the quarter.
- Wilmington Savings Fund Society sold 132 Neurogene shares in Q1 2025, an estimated $3.02K.
- Wilmington Savings Fund Society first reported a position in Neurogene in Q4 2024 and held it in 1 quarter.
- Wilmington Savings Fund Society's Neurogene position peaked at $3.02K in Q4 2024.
- 85 funds tracked by Wall St. Rank held Neurogene as of Q1 2025.
Based on Wilmington Savings Fund Society's 13F filing for Q1 2025, filed 8 May 2025.